Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Stanford University | OTHER |
| Tidepool Project | UNKNOWN |
| RileyLink | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
An observational study to collect data on the efficacy, safety, usability, and quality of life/psychosocial effects of the Loop DIY automated insulin delivery system.
The study will include both adults and youth in the United States, with a recruitment goal of at least 300-1,250 participants. Data to be collected to address the study objective will include CGM metrics; HbA1c; insulin delivery data; carbohydrate data; activity data from HealthKit; self-reported adverse events (e.g., severe hypoglycemia, diabetic ketoacidosis, hospitalizations); self-reported device issues; and psychosocial and user experience/treatment satisfaction surveys.
Online forms will allow participants to report weekly device issues and serious adverse events including severe hypoglycemia, diabetic ketoacidosis, and hospitalizations. General data updates will be obtained after three, six, and 12 months (and every six months thereafter if study participation continues). A fingerstick blood sample will be collected for HbA1c measurement after three months for cohort A and after six and 12 months for both cohorts. Quality-of-life/psychosocial and treatment satisfaction questionnaires will be completed after six and 12 months; new users also will complete questionnaires after 3 months. Virtual focus groups will be completed within the first three months of starting Loop and at 12 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Cohort A | Individuals who have not started Loop or who have been on Loop fewer than 7 days at the time of enrollment. |
| |
| Cohort B | Participants who have been using Loop 7 or more days at the time of enrollment. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Loop | Device | The Loop System consists of an insulin pump (certain versions of Medtronic insulin pumps) and a Dexcom or Medtronic CGM. The system includes an iPhone with the Loop app and a RileyLink to communicate between the pump and iPhone. An Apple Watch may optionally be used with the system. |
| Measure | Description | Time Frame |
|---|---|---|
| Measure of Loop Safety by Self-Report of Diabetic Ketoacidosis (DKA) Events | Number of DKA events and event outcomes on the Adverse Event and Device Issue - Loop survey. DKA events are defined as the development of ketones with a diagnosis of DKA by a medical provider. | 6 Months |
| Measure of Loop Safety by Self-Report of Severe Hypoglycemic Events | Number of severe hypoglycemic events and event outcomes on the Adverse Event and Device Issue - Loop survey. Severe hypoglycemia is defined as low blood sugar that affected the individual's ability to think such that they were unable to treat themselves and needed assistance from someone else. The individual may or may not have lost consciousness. | 6 Months |
| Measure of Loop Safety by Self-Report of Hospitalization Events | Number of hospitalizations and event outcomes on the Adverse Event and Device Issue - Loop survey. | 6 Months |
| Measure | Description | Time Frame |
|---|---|---|
| Measure of Loop Safety by Self-Report of Diabetic Ketoacidosis (DKA) Events | Number of DKA events and event outcomes on the Adverse Event and Device Issue - Loop survey. DKA events are defined as the development of ketones with a diagnosis of DKA by a medical provider. | 12 Months |
| Measure of Loop Safety by Self-Report of Severe Hypoglycemic Events |
| Measure | Description | Time Frame |
|---|---|---|
| Loop Baseline General Data Collection | Self-report participant's basic information. No scale provided, variable responses. | Enrollment |
| Summary statistics for CGM metrics | Continuous CGM data from participant's Tidepool account. |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Individuals using or planning to use the Loop system
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John Lum, MS | Jaeb Center for Health Research | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Jaeb Center for Health Research | Tampa | Florida | 33647 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35099278 | Derived | Suttiratana SC, Wong JJ, Lanning MS, Dunlap A, Hanes SJ, Hood KK, Lal RA, Naranjo D. Qualitative Study of User Experiences with Loop, an Open-Source Automated Insulin Delivery System. Diabetes Technol Ther. 2022 Jun;24(6):416-423. doi: 10.1089/dia.2021.0485. Epub 2022 May 12. | |
| 34780283 | Derived | Wong JJ, Suttiratana SC, Lal RA, Lum JW, Lanning MS, Dunlap A, Arbiter B, Hanes SJ, Bailey RJ, Hood KK, Naranjo D. Discontinued Use of the Loop Insulin Dosing System: A Mixed-Methods Investigation. Diabetes Technol Ther. 2022 Apr;24(4):241-248. doi: 10.1089/dia.2021.0362. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
|
Number of severe hypoglycemic events and event outcomes on the Adverse Event and Device Issue - Loop survey. Severe hypoglycemia is defined as low blood sugar that affected the individual's ability to think such that they were unable to treat themselves and needed assistance from someone else. The individual may or may not have lost consciousness. |
| 12 Months |
| Measure of Loop Safety by Self-Report of Hospitalization Events | Number of hospitalizations and event outcomes on the Adverse Event and Device Issue - Loop survey. | 12 Months |
| 6 months and 12 months |
| Loop Additional Form for Current Loop Users | Self-report of participant's use of Loop and Loop related features. No scale provided, variable responses. | Enrollment (cohort B), 3 Months (cohort A), 6 Months, and 12 Months |
| LoopHoles Survey | Self-report of participant's patterns of Loop use. No scale provided, variable responses. | Enrollment (cohort B), 3 Months (cohort A), 6 Months, and 12 Months |
| Pittsburgh Sleep Quality Index | Standardized questionnaire and scoring. Usual sleeping habits for past month. Questions 1 - 9. Overall scores range from 0 to 21, with lower values representing better sleep quality. | Enrollment, 3 Months (cohort A), 6 Months, and 12 Months |
| Satisfaction of diabetes technology. | Standardized Diabetes Technology Attitudes - 5 with likert scale questions. Each question is scored on a scale of 1 to 5, with a higher score indicating greater satisfaction with diabetes technology. | Enrollment, 3 Months (cohort A), 6 Months, and 12 Months |
| Automated Insulin Delivery Satisfaction | Change in satisfaction of using Loop. Measured using the standardized INSPIRE (Adult, Parent, and Child) questionnaires. The higher the score the more positive the opinion that automated insulin delivery has had a positive impact on the participant's life. | Enrollment (Cohort B), Month 3 (Cohort A), Month 6, Month 12 |
| HbA1c | Blood sample. | Enrollment, Month 3 (Cohort A), Month 6, Month 12 |
| Device issues related to Loop | Weekly self-report of any device issues that interfered with their ability to use Loop on the Adverse Event and Device Issue - Loop survey. No scale provided. | Weekly from 7 days after enrollment to 12 months |
| Hypoglycemia Confidence Scale | Standardized questionnaire. Confidence of managing hypoglycemia during daily tasks. Overall scores range from 1 to 4, with higher scores indicating greater confidence in managing hypoglycemia. | Enrollment, Month 3 (Cohort A), Month 6, Month 12 |
| Hypoglycemia Fear Survey - Worry Scale | Standardized survey. Measures level of worry of low blood sugar, for Adult, Parent, and Child. Items are rated on a 5 point Likert scale from 0 to 4. Total scores and sub-scale scores are sum scores of all relative items. For the adult survey, the score ranges from 0-52. For the children's survey, the score ranges from 0-60. For the parent survey, the score ranges from 0-60. A higher score indicates greater fear of hypoglycemia. | Enrollment, Month 3 (Cohort A), Month 6, Month 12 |
| Risk Taking Questions | Standardized questionnaire about risk taking behavior. Items are scored on a scale of 1 to 10, with a higher score indicating a greater disposition to take risks. | Enrollment, Month 3 (Cohort A), Month 6, Month 12 |
| T1-DDS (Management Distress Items) | Standardized questionnaire. Feelings about diabetes management. Overall scores range from 1 to 6, with higher scores indicating higher distress over diabetes management. | Enrollment, Month 3 (Cohort A), Month 6, Month 12 |
| Device Discontinuation or Non-start Reasons | No scale questionnaire allowing varied responses about why participant's stopped using Loop or why they never started. | Up to 12 months, as needed |
| Loop Follow-Up General Data Collection | Self-report of participant's basic information. No scale provided, variable responses. | Month 3 (Cohort A), Month 6, Month 12 |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |